Humanigen Inc (fka HGENQ)

[cowtown jay]

The "failed" transaction had nothing to do with Baudax, the subject company of my post. I was a little disappointed that the merger with them wasn't announced already today. However, I don't think the merger will be announced in a "stand alone" press release or filing, so I still look forward to that announcement, with whatever other news is released with that.

Note: "The Company’s negotiations with a privately held biopharmaceutical company relating to a proposed business combination, as disclosed in the Company’s Quarterly Report on Form 10-Q filed on May 15, 2023, have ended without execution of a definitive agreement."

https://www.sec.gov/ix?doc=/Archives/edgar/data/1293310/000121465923009927/j7242308k.htm

Baudax is publicly traded, not privately held. We already had a partnership agreement with the privately-owned PCI Pharma before announcing our intention of a business combination, which I still think may be with PCI. The fact that the business combination negotiation ended without a definitive agreement, doesn't preclude a subsequent successful negotiation.

But the quoted information from the filing is the same disclosure we saw from Kalobios, which included a Ch 11, from which the share structure remained intact.

I've already indicated how I feel about repeating that process.

"I think a share recall will be announced, and then a 5:1 forward stock split will be declared.

https://valueofstocks.com/2022/06/01/share-recall/

And then I hope we don't hear another peep about a bankruptcy."

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172549203

Mechanistically, I don't know why a bankruptcy filing has to be incorporated into our corporate actions. We're too close to success for another baptism under water.

But I disagree that what lenz can do doesn't matter. What lenz can do in CMML and covid is ALL that matters. And those results include Q2's PREACH-M study results, which led to the company and the Principal Investigator to initiating an effort to gain potential approval in Australia, which appears to be in-process and may be the result we are waiting to announce. It most certainly is the result I am banking on, possibly with covid treatment approval from the UK.

https://s28.q4cdn.com/539885110/files/doc_news/Humanigen-Presents-Promising-New-Hematologic-Data-from-PREACH-M-Trial-for-Chronic-Myelomonocytic-Leukemia-Treatment-at-the-2023-Europ-OYZCQ.pdf

However, I fully understand your concern.